deltatrials
Unknown OBSERVATIONAL NCT04785495

Prevalence of Anticipatory Nausea and Vomiting in Cancer Patients Exposed to Highly Emetogenic Chemotherapy

Sponsor: Instituto Brasileiro de Controle do Cancer

Conditions Chemotherapy-induced Nausea and Vomiting
Interventions Quality-of-life assessment
Updated 4 times since 2021 Last updated: Mar 4, 2021 Started: Aug 12, 2020 Primary completion: Aug 31, 2021 Completion: Nov 30, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Chemotherapy-induced Nausea and Vomiting and is currently ongoing. Instituto Brasileiro de Controle do Cancer leads this study, which shows 4 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Apr 2021 – ~Jan 2023 · 21 months · monthly snapshotRecruiting~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

4 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown

    Status: Unknown Status → Unknown

  3. Jan 2023 — Jul 2024 [monthly]

    Unknown Status

    Status: Recruiting → Unknown Status

  4. Apr 2021 — Jan 2023 [monthly]

    Recruiting

    First recorded

Aug 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Instituto Brasileiro de Controle do Cancer
Data source: Instituto Brasileiro de Controle do Cancer

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations